SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of Earliest Event Reported): April 29, 2003
Caremark Rx, Inc.
(Exact Name
of Registrant as Specified in its Charter)
| Delaware (State or Other Jurisdiction of Incorporation) |
0-14200 (Commission File Number) |
63-1151076 (I.R.S. Employer Identification No.) |
||
3000 Galleria Tower, Suite 1000 Birmingham, Alabama (Address of Principal Executive Offices) |
35244 (Zip Code) |
|||
Registrant's Telephone Number, Including Area Code (205) 733-8996
Item 9. Regulation FD Disclosure
The information contained in this Item 9 is being furnished to the Securities and Exchange Commission (the "Commission") pursuant to Item 12 of Form 8-K, "Results of Operations and Financial Condition," as directed by the Commission in Release No. 34-47583.
On April 29, 2003, Caremark Rx, Inc. (the "Company") issued a press release disclosing material, non-public financial information concerning the Company's quarterly fiscal period ended March 31, 2003. This press release contains certain non-GAAP financial measures as described therein. A copy of this press release is attached hereto as Exhibit 99.1.
1
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
| Caremark Rx, Inc. | ||||
By: |
/s/ HOWARD A. MCLURE Howard A. McLure Executive Vice President and Chief Financial Officer |
|||
Date: April 29, 2003
2